Applications of machine learning in GPCR bioactive ligand discovery, Curr. Opin. Struct. Biol, vol.55, pp.66-76, 2019. ,
Ligand Docking and Structure-based Virtual Screening in Drug Discovery, Curr. Top. Med. Chem, vol.7, pp.1015-1023, 2007. ,
Drug repositioning by structure-based virtual screening, Chem. Soc. Rev, vol.42, pp.2130-2141, 2013. ,
How far can virtual screening take us in drug discovery?, Expert Opin. Drug Discov, vol.8, pp.245-261, 2013. ,
Targeting the proangiogenic VEGF-VEGFR protein-protein interface with drug-like compounds by in silico and in vitro screening, Chem. Biol, vol.18, pp.1631-1639, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01061760
In silico prediction of aqueous solubility: A multimodel protocol based on chemical similarity, Mol. Pharm, vol.9, pp.3127-3135, 2012. ,
Sampling of conformational ensemble for virtual screening using molecular dynamics simulations and normal mode analysis, Future Med. Chem, vol.7, pp.2317-2331, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01274987
Classical scoring functions for docking are unable to exploit large volumes of structural and interaction data, Bioinformatics, 2019. ,
Recognizing pitfalls in virtual screening: A critical review, J. Chem. Inf. Modeling, vol.52, pp.867-881, 2012. ,
Machine-learning scoring functions to improve structure-based binding affinity prediction and virtual screening, Wiley Interdiscip. Rev. Comput. Mol. Sci, vol.5, pp.405-424, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01787236
Improvements, trends, and new ideas in molecular docking: 2012-2013 in review, J. Mol. Recognit, vol.28, pp.581-604, 2015. ,
A computational-aided drug design web server, Nucleic Acids Res, vol.38, pp.615-621, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00497221
SwissDock, a protein-small molecule docking web service based on EADock DSS, Nucleic Acids Res, vol.39, pp.270-277, 2011. ,
CovalentDock Cloud: A web server for automated covalent docking, Nucleic Acids Res, vol.41, pp.329-332, 2013. ,
CSM-lig: A web server for assessing and comparing protein-small molecule affinities, Nucleic Acids Res, vol.44, pp.557-561, 2016. ,
World's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan, J. Comput.-Aided Mol. Des, vol.25, pp.525-531, 2011. ,
Automated docking screens: A feasibility study, J. Med. Chem, vol.52, pp.5712-5720, 2009. ,
USR-VS: A web server for large-scale prospective virtual screening using ultrafast shape recognition techniques, Nucleic Acids Res, vol.44, pp.436-441, 2016. ,
, Free ADME-tox filtering computations for chemical biology and early stages drug discovery. Bioinform. (Oxf. Engl, vol.33, pp.3658-3660, 2017.
A web server for structure-based virtual screening, Nucleic Acids Res, vol.43, pp.448-454, 2015. ,
AMMOS2: A web server for protein-ligand-water complexes refinement via molecular mechanics, Nucleic Acids Res, vol.45, pp.350-355, 2017. ,
RPBS: A web resource for structural bioinformatics, Nucleic Acids Res, vol.33, pp.44-49, 2005. ,
URL : https://hal.archives-ouvertes.fr/inria-00180478
New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays, J. Med. Chem, vol.53, pp.2719-2740, 2010. ,
FAF-Drugs: Free ADME/tox filtering of compound collections, Nucleic Acids Res, vol.34, pp.738-744, 2006. ,
URL : https://hal.archives-ouvertes.fr/inserm-00106930
Physiochemical drug properties associated with in vivo toxicological outcomes, Bioorg. Med. Chem. Lett, vol.18, pp.4872-4875, 2008. ,
Generation of a set of simple, interpretable ADMET rules of thumb, J. Med. Chem, vol.51, pp.817-834, 2008. ,
How does the quality of phospholipidosis data influence the predictivity of structural alerts?, J. Chem. Inf. Modeling, vol.54, pp.2224-2232, 2014. ,
Rules for identifying potentially reactive or promiscuous compounds, J. Med. Chem, vol.55, pp.9763-9772, 2012. ,
Frog2: Efficient 3D conformation ensemble generator for small compounds, Nucleic Acids Res, vol.38, pp.622-627, 2010. ,
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility, J. Comput. Chem, vol.30, pp.2785-2791, 2009. ,
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem, pp.455-461, 2010. ,
Online structure-based screening of purchasable approved drugs and natural compounds: Retrospective examples of drug repositioning on cancer targets, Oncotarget, vol.9, pp.32346-32361, 2018. ,
Protein-protein interaction inhibitors get into the groove, Nat. Rev. Drug Discov, vol.11, pp.173-175, 2012. ,
Focused chemical libraries-design and enrichment: An example of protein-protein interaction chemical space, Future Med. Chem, vol.6, pp.1291-1307, 2014. ,
Drug-like protein-protein interaction modulators: Challenges and opportunities for drug discovery and chemical biology, Mol. Inform, vol.33, pp.414-437, 2014. ,
Molecular mechanics calculations on Rous sarcoma virus protease with peptide substrates, Protein Sci.: A Publ. Protein Soc, vol.6, pp.2365-2374, 1997. ,
Automated Molecular Mechanics Optimization tool for in silico Screening, BMC Bioinform, vol.9, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00668481
The pharmacology of penfluridol (R 16341) a new potent and orally long-acting neuroleptic drug, Eur. J. Pharmacol, vol.11, pp.139-154, 1970. ,
Experimental comparison of low doses of 1.5 mg fluspirilene and bromazepam in out-patients with psychovegetative disturbances, Pharmacopsychiatry, vol.18, pp.297-302, 1985. ,
Inhibition of glutamate release by fluspirilene in cerebrocortical nerve terminals (synaptosomes), Synapse, vol.44, pp.36-41, 2002. ,
In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug, PLoS ONE, vol.10, 2015. ,
The history and future of targeting cyclin-dependent kinases in cancer therapy, Nat. Rev. Drug Discov, vol.14, pp.130-146, 2015. ,
Benefit-risk assessment of raloxifene in postmenopausal osteoporosis, Drug Saf, vol.28, pp.721-730, 2005. ,
Mechanism of action and preclinical profile of raloxifene, a selective estrogen receptor modulation, Rev. Endocr. Metab. Disord, vol.2, pp.129-138, 2001. ,
Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: Discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface, J. Med. Chem, vol.57, pp.632-641, 2014. ,
Targeting the IL-6/JAK/STAT3 signalling axis in cancer, Nat. Rev. Clin. Oncol, vol.15, pp.234-248, 2018. ,
Thalidomide-induced teratogenesis: History and mechanisms, Birth Defects Res. Part C Embryo Today Rev, vol.105, pp.140-156, 2015. ,
Antitumor activity of thalidomide in refractory multiple myeloma, New Engl. J. Med, vol.341, pp.1565-1571, 1999. ,
How thalidomide works against cancer, vol.343, pp.256-257, 2014. ,
Open Babel: An open chemical toolbox, J. Cheminformatics, vol.3, 2011. ,
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev, vol.46, pp.3-26, 2001. ,
A 'rule of three' for fragment-based lead discovery?, Drug Discov. Today, vol.8, pp.876-877, 2003. ,
Probing the probes: Fitness factors for small molecule tools, Chem. Biol, vol.17, pp.561-577, 2010. ,
Filtering databases and chemical libraries, Mol. Divers, vol.5, pp.185-197, 2002. ,
ZINC-a free database of commercially available compounds for virtual screening, J. Chem. Inf. Modeling, vol.45, pp.177-182, 2005. ,
Assessment of the blood-brain barrier in CNS drug discovery, Neurobiol. Dis, vol.37, pp.33-37, 2010. ,
Analysis of the calculated physicochemical properties of respiratory drugs: Can we design for inhaled drugs yet?, J. Chem. Inf. Modeling, vol.49, pp.1025-1032, 2009. ,
, 3D structure collections dedicated to drug repurposing and fragment-based drug design. Bioinform, vol.28, pp.1540-1541, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02115767
pv: v1.8.1 (Version V1.8.1), p.18, 2015. ,
UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations, J. Am. Chem. Soc, vol.114, pp.10024-10035, 1992. ,
An all atom force field for simulations of proteins and nucleic acids, J. Comput. Chem, vol.7, pp.230-252, 1986. ,
PLIP: Fully automated protein-ligand interaction profiler, Nucleic Acids Res, vol.43, pp.443-447, 2015. ,
ChEMBL: A large-scale bioactivity database for drug discovery, Nucleic Acids Res, vol.40, pp.1100-1107, 2012. ,
, Nucleic Acids Res, vol.46, pp.1074-1082, 2018.
, Online drug compendium, vol.45, pp.932-939, 2017.
SuperDRUG2: A one stop resource for approved/marketed drugs, Nucleic Acids Res, vol.46, pp.1137-1143, 2018. ,
FAF-Drugs3: A web server for compound property calculation and chemical library design, Nucleic Acids Res, vol.43, pp.200-207, 2015. ,
ZINC 15-Ligand Discovery for Everyone, J. Chem. Inf. Modeling, vol.55, pp.2324-2337, 2015. ,
Available online: www.chemaxon.com (accessed on 18, vol.23, 2019. ,
Available online: www.mn-am.com (accessed on 18, Molecular Networks GmbH, 2019. ,
UCSF Chimera-a visualization system for exploratory research and analysis, J. Comput. Chem, vol.25, pp.1605-1612, 2004. ,
, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2019 by the authors. Licensee MDPI